SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,945 | +5.6% | 2,300 | -4.2% | 0.31% | +12.1% |
| Q2 2023 | $461,904 | -6.5% | 2,400 | -2.8% | 0.27% | -5.5% |
| Q1 2023 | $494,000 | +55.6% | 2,470 | 0.0% | 0.29% | +51.3% |
| Q4 2022 | $317,420 | -6.1% | 2,470 | 0.0% | 0.19% | -14.3% |
| Q3 2022 | $338,000 | -26.5% | 2,470 | -5.0% | 0.22% | -21.2% |
| Q2 2022 | $460,000 | +22.7% | 2,600 | 0.0% | 0.28% | +36.7% |
| Q1 2022 | $375,000 | +4.5% | 2,600 | 0.0% | 0.21% | +2.5% |
| Q4 2021 | $359,000 | -18.6% | 2,600 | 0.0% | 0.20% | -18.5% |
| Q3 2021 | $441,000 | +4.5% | 2,600 | -3.7% | 0.25% | +6.9% |
| Q2 2021 | $422,000 | +7.9% | 2,700 | 0.0% | 0.23% | +2.7% |
| Q1 2021 | $391,000 | -18.9% | 2,700 | -3.6% | 0.23% | -26.6% |
| Q4 2020 | $482,000 | – | 2,800 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |